Evidence map›Paper›PMID 23362262›Full record

ArticleThe Journal of biological chemistry2013

Transforming growth factor β integrates Smad 3 to mechanistic target of rapamycin complexes to arrest deptor abundance for glomerular mesangial cell hypertrophy.

Falguni Das, Nandini Ghosh-Choudhury, Amit Bera, Nirmalya Dey, Hanna E Abboud, Balakuntalam S Kasinath, Goutam Ghosh Choudhury

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. TGF-β: the master regulator of fibrosis.Nature reviews. Nephrology · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Falguni DasDepartment of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229.
Nandini Ghosh-ChoudhuryDepartment of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229; Veterans Affairs Research, South Texas Veterans Health Care System, San Antonio, Texas 78229.
Amit BeraDepartment of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229.
Nirmalya DeyDepartment of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229.
Hanna E AbboudDepartment of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229; Veterans Affairs Research, South Texas Veterans Health Care System, San Antonio, Texas 78229.
Balakuntalam S KasinathDepartment of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229; Veterans Affairs Research, South Texas Veterans Health Care System, San Antonio, Texas 78229.
Goutam Ghosh ChoudhuryDepartment of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229; Veterans Affairs Research, South Texas Veterans Health Care System, San Antonio, Texas 78229; Geriatric Research, Education and Clinical Center, South Texas Veterans Health Care System, San Antonio, Texas 78229. Electronic address: choudhuryg@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · USSouth Texas Veterans Health Care System · US

Funding

Mechanism of Renal Cell Injury in DiabetesR01DK050190 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GHOSH CHOUDHURY, GOUTAM · 2004 to 2013
$2.3M
Novel mechanisms of diabetic nephropathyR01DK077295 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KASINATH, BALAKUNTALAM S · 2007 to 2011
$1.3M
Renal Cell Response in DiabetesR01DK078971 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ABBOUD, HANNA E · 2008 to 2012
$1.2M
Redox Signaling in Osteoblast DifferentiationR01AR052425 · NIAMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GHOSH-CHOUDHURY, NANDINI · 2005 to 2009
$1.1M
CCR NIH HHS RC2A036613NIAMS NIH HHS R01 AR052425NIAMS NIH HHS R01 AR 52425NIDDK NIH HHS R01 DK050190NIDDK NIH HHS R01 DK 077295NIDDK NIH HHS R01 DK077295NIDDK NIH HHS R01 DK078971NIDDK NIH HHS R01 DK50190NIDDK NIH HHS R01 DK 78971
6 · The paper itself

Abstract

In many renal diseases, transforming growth factor β (TGFβ)-stimulated canonical Smad 3 and noncanonical mechanistic target of rapamycin (mTOR) promote increased protein synthesis and mesangial cell hypertrophy. The cellular underpinnings involving these signaling molecules to regulate mesangial cell hypertrophy are not fully understood. Deptor has recently been identified as an mTOR interacting protein and functions as an endogenous inhibitor of the kinase activity for both TORC1 and TORC2. Prolonged incubation of mesangial cells with TGFβ reduced the levels of deptor concomitant with an increase in TORC1 and TORC2 activity. Sustained TGFβ activation was required to inhibit association of deptor with mTOR, whereas rapid activation had no effect. Using the mTOR inhibitor PP242, we found that TGFβ-induced both early and sustained activation of TORC1 and TORC2 was necessary for deptor suppression. PP242-induced reversal of deptor suppression by TGFβ was associated with a significant inhibition of TGFβ-stimulated protein synthesis and hypertrophy. Interestingly, expression of siRNA against Smad 3 or Smad 7, which blocks TGFβ receptor-specific Smad 3 signaling, prevented TGFβ-induced suppression of deptor abundance and TORC1/2 activities. Furthermore, overexpression of Smad 3 decreased deptor expression similar to TGFβ stimulation concomitant with increased TORC1 and TORC2 activities. Finally, knockdown of deptor reversed Smad 7-mediated inhibition of protein synthesis and mesangial cell hypertrophy induced by TGFβ. These data reveal the requirement of both early and late activation of mTOR for TGFβ-induced protein synthesis. Our results support that TGFβ-stimulated Smad 3 acts as a key node to instill a feedback loop between deptor down-regulation and TORC1/2 activation in driving mesangial cell hypertrophy.

Indexed as

AdenoviridaeCells, CulturedGene Expression RegulationGlomerular MesangiumHumansHypertrophyMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Models, BiologicalMultiprotein ComplexesProtein Serine-Threonine KinasesRecombinant ProteinsSignal TransductionSmad3 ProteinTOR Serine-Threonine KinasesTransforming Growth Factor betaMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MTOR protein, humanMultiprotein ComplexesProtein Serine-Threonine KinasesRecombinant ProteinsSmad3 ProteinSMAD3 protein, humanTOR Serine-Threonine KinasesTransforming Growth Factor beta

Identifiers

PMID23362262
PMCPMC3597815
OpenAlexW2122341300

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.